These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32192977)

  • 1. Acute Myeloid Leukemia in Mexico: The Specific Challenges of a Developing Country. Results From a Multicenter National Registry.
    Demichelis-Gómez R; Zapata-Canto N; Leyto-Cruz F; Terreros-Muñoz E; Carrillo A; Montaño-Figueroa E; Solís-Poblano JC; Colunga-Pedraza P; Díaz-Vargas G; Amador-Medina LF; Martínez-Hernández R; Turrubiates F; Cabrera-García A; Zaragoza A; Espinoza R; Gutiérrez-Serdán R; Apodaca E; Moreira C; García-Castillo C; García-Stivalet L; Limón A; Gómez-Almaguer D; Rozen-Fuller E; Espinosa-Bautista KA; Crespo-Solís E; Meillón L
    Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):e295-e303. PubMed ID: 32192977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies.
    Li D; Wang L; Zhu H; Dou L; Liu D; Fu L; Ma C; Ma X; Yao Y; Zhou L; Wang Q; Wang L; Zhao Y; Jing Y; Wang L; Li Y; Yu L
    PLoS One; 2015; 10(7):e0132620. PubMed ID: 26197471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Østgård LSG; Lund JL; Nørgaard JM; Nørgaard M; Medeiros BC; Nielsen B; Nielsen OJ; Overgaard UM; Kallenbach M; Marcher CW; Riis AH; Sengeløv H
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):314-323. PubMed ID: 29051022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis.
    Michelis FV; Gupta V; Zhang MJ; Wang HL; Aljurf M; Bacher U; Beitinjaneh A; Chen YB; DeFilipp Z; Gale RP; Kebriaei P; Kharfan-Dabaja M; Lazarus HM; Nishihori T; Olsson RF; Oran B; Rashidi A; Rizzieri DA; Tallman MS; de Lima M; Khoury HJ; Sandmaier BM; Weisdorf D; Saber W;
    Cancer; 2017 Jun; 123(11):2035-2042. PubMed ID: 28117898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years.
    Cornelissen JJ; Versluis J; Passweg JR; van Putten WL; Manz MG; Maertens J; Beverloo HB; Valk PJ; van Marwijk Kooy M; Wijermans PW; Schaafsma MR; Biemond BJ; Vekemans MC; Breems DA; Verdonck LF; Fey MF; Jongen-Lavrencic M; Janssen JJ; Huls G; Kuball J; Pabst T; Graux C; Schouten HC; Gratwohl A; Vellenga E; Ossenkoppele G; Löwenberg B; ;
    Leukemia; 2015 May; 29(5):1041-50. PubMed ID: 25428261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cells transplantation improves the survival of intermediate-risk acute myeloid leukemia patients aged less than 60 years.
    Zhang Y; Zhang Y; Chen Q; Tang G; Zhang W; Yang J; Wang J; Hu X
    Ann Hematol; 2019 Apr; 98(4):997-1007. PubMed ID: 30607578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study.
    Ustun C; Le-Rademacher J; Wang HL; Othus M; Sun Z; Major B; Zhang MJ; Storrick E; Lafky JM; Chow S; Mrózek K; Attar EC; Nand S; Bloomfield CD; Cripe LD; Tallman MS; Appelbaum F; Larson RA; Marcucci G; Roboz GJ; Uy GL; Stone RM; Jatoi A; Shea TC; de Lima M; Foran JM; Sandmaier BM; Litzow MR; Erba HP; Hurria A; Weisdorf DJ; Artz AS
    Leukemia; 2019 Nov; 33(11):2599-2609. PubMed ID: 31073153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation.
    Gilleece MH; Labopin M; Yakoub-Agha I; Volin L; Socié G; Ljungman P; Huynh A; Deconinck E; Wu D; Bourhis JH; Cahn JY; Polge E; Mohty M; Savani BN; Nagler A
    Am J Hematol; 2018 Sep; 93(9):1142-1152. PubMed ID: 29981272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
    Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
    Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories.
    Cornelissen JJ; Breems D; van Putten WL; Gratwohl AA; Passweg JR; Pabst T; Maertens J; Beverloo HB; van Marwijk Kooy M; Wijermans PW; Biemond BJ; Vellenga E; Verdonck LF; Ossenkoppele GJ; Löwenberg B
    J Clin Oncol; 2012 Jun; 30(17):2140-6. PubMed ID: 22564995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
    Limvorapitak W; Barnett MJ; Hogge DE; Forrest DL; Nevill TJ; Narayanan S; Power MM; Nantel SH; Broady R; Song KW; Toze CL; Mourad YA; Sutherland HJ; Gerrie AS; White J; Sanford DS
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e481-e491. PubMed ID: 30100330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.
    Grosicki S; Holowiecki J; Kuliczkowski K; Skotnicki A; Hellmann A; Kyrcz-Krzemien S; Dmoszynska A; Sułek K; Kloczko J; Jedrzejczak WW; Warzocha K; Zdziarska B; Wierzbowska A; Pluta A; Komarnicki M; Giebel S
    Am J Hematol; 2015 Oct; 90(10):904-9. PubMed ID: 26149802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA.
    Schlenk RF; Taskesen E; van Norden Y; Krauter J; Ganser A; Bullinger L; Gaidzik VI; Paschka P; Corbacioglu A; Göhring G; Kündgen A; Held G; Götze K; Vellenga E; Kuball J; Schanz U; Passweg J; Pabst T; Maertens J; Ossenkoppele GJ; Delwel R; Döhner H; Cornelissen JJ; Döhner K; Löwenberg B
    Blood; 2013 Aug; 122(9):1576-82. PubMed ID: 23863898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Beelen D; Ciceri F; Volin L; Shimoni A; Foá R; Milpied N; Peccatori J; Polge E; Mailhol A; Mohty M; Savani BN
    Cancer; 2017 Jul; 123(14):2671-2679. PubMed ID: 28329410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Autologous Stem Cell Transplantation versus Haploidentical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete Remission.
    Chen J; Yang L; Fan Y; Xu Y; Han Y; Tang X; Qiu H; Fu C; Miao M; Chen F; Wu D
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):779-788. PubMed ID: 29289758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Harada K; Konuma T; Machida S; Mori J; Aoki J; Uchida N; Ohashi K; Fukuda T; Tanaka M; Ikegame K; Ozawa Y; Iwato K; Eto T; Onizuka M; Ichinohe T; Atsuta Y; Yano S
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1730-1743. PubMed ID: 31054982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
    Zahler S; Bhatia M; Ricci A; Roy S; Morris E; Harrison L; van de Ven C; Fabricatore S; Wolownik K; Cooney-Qualter E; Baxter-Lowe LA; Luisi P; Militano O; Kletzel M; Cairo MS
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):698-704. PubMed ID: 26785332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non-High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts.
    Adrianzen Herrera D; Kornblum N; Derman O; Bachier-Rodriguez L; Sica RA; Shastri A; Janakiram M; Verma A; Braunschweig I; Mantzaris I
    Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):516-521. PubMed ID: 31227357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of children with high-risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML-05 clinical trial.
    Hyakuna N; Hashii Y; Ishida H; Umeda K; Takahashi Y; Nagasawa M; Yabe H; Nakazawa Y; Koh K; Goto H; Fujisaki H; Matsumoto K; Kakuda H; Yano M; Tawa A; Tomizawa D; Taga T; Adachi S; Kato K
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27875. PubMed ID: 31309713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center.
    Jaime-Pérez JC; Padilla-Medina JR; Fernández LT; Herrera-Garza JL; Gutiérrez-Aguirre CH; Tarín-Arzaga L; Gómez-Almaguer D
    Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):286-292. PubMed ID: 29478946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.